CH
IMNP

CVI Holdings’s Immune Pharmaceuticals Inc. IMNP Stock Holding History

CVI Holdings’s Portfolio IMNP Stock Details IMNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-251,029
Closed -$47K – 66
2018
Q2 		$47K Buy
+251,029
New +$71K 0.06% 39

Other funds holding IMNP

IP
Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return

CVI Holdings's IMNP Position: Q3 2018 in Review

CVI Holdings sold out of Immune Pharmaceuticals Inc. (IMNP) in Q3 2018, closing a stake of 251,029 shares — an estimated $47K sold.

CVI Holdings first reported a position in IMNP in Q2 2018 and held it in 1 quarter. The position peaked at $47K in Q2 2018. 1 fund tracked by Wall St. Rank holds IMNP as of Q3 2018.

  • CVI Holdings reported no remaining Immune Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • CVI Holdings sold 251,029 Immune Pharmaceuticals Inc. shares in Q3 2018, an estimated $47K.
  • CVI Holdings first reported a position in Immune Pharmaceuticals Inc. in Q2 2018 and held it in 1 quarter.
  • CVI Holdings's Immune Pharmaceuticals Inc. position peaked at $47K in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Immune Pharmaceuticals Inc. as of Q3 2018.

Based on CVI Holdings's 13F filing for Q3 2018, filed 14 Nov 2018.